The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer

Anticancer Research

Volumn 22, Issue 3, 2002, Pages 1925-1928

  Lantzsch, Tilmann ^a   Hefler, Lukas ^a   Krause, Ulf ^a   Kehl, Alexandra ^a   Goepel, Christiiian ^a   Koelbl, Heinz ^a   Dunst, Juergen ^a   Lampe, Dieter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiogenesis; Breast cancer; Intratumoral microvessel density; Vascular endothelial growth factor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LYMPHOKINES; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036330702     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Angiogenesis in cancer, vascular, rheumatoid, and other disease
2. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
3. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
5. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
6. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer
7. Vascular endothelial growth factor serum concentrations in ovarian cancer
8. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival
9. Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen
10. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
11. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor
12. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma
13. Serum VEGF levels in women with a benign breast tumor or breast cancer
14. Clinical significance of angiogenic factors in breast cancer
15. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
16. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
17. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
18. Biological properties of VEGF/VPF receptors
19. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
20. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer
21. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
22. Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery?
23. Chemotherapy and angiogenesis in advanced cancer: Vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer
24. Surrogate markers of tumoral angiogenesis
25. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue
26. TNP-470: An angiogenesis inhibitor in clinical development for cancer
27. Serum evaluation of basic FGF in breast cancer patients
28. Serum level of angiogenin in breast cancer
29. Circulating vascular endothelial growth factor in patients with colorectal cancer
30. Serum concentrations of vascular endothelial growth factor in vulvar cancer
31. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
32. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: Correlation with clinicopathological factors and tumor markers
33. Platelet: Transporter of vascular endothelial growth factor
34. In vitro release of vascular endothelial growth factor during platelet aggregation
35. Activated human neutrophils express vascular endothelial growth factor (VEGF)
36. Angiogenesis in malignancies of the female genital tract